Insider Stock Trading History of Yocum Richard C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Yocum Richard C since year 2005. The trader's CIK number is 1323495. At the time of this reporting, Yocum Richard C is the VP Clinical Developm of Halozyme Therapeutics Inc . (stock ticker symbol HTI). See this page for all insider trading activities at Halozyme Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Yocum Richard C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-03-22 HTI Halozyme Therapeutics Inc Sale 29,858 8.51 254,091
2007-03-21 HTI Halozyme Therapeutics Inc Option Ex 95,833 1.87 179,207

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yocum Richard C (VP Clinical Developm of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.